TRUPNasdaqHospital & Medical Service PlansFiscal year ends December 31
TRUPANION, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$27.50−0.62 (-2.20%)
Close on Oct 19, 2026
- Market cap
- $1.21B
- P/E (TTM)
- 51.9
- Dividend yield
- –
Share price
−$15.40 (−35.90%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
TRUPANION, INC. grew revenue 11.8% to $1.52B over the twelve months to Jun 30, 2026. Operating income rose 722.8% to $24.15M, moving the operating margin from 0.2% to 1.6%. Free cash flow was $82.18M, up 34.0% from a year earlier.
Revenue
$1.52B
+11.8% vs. a year earlier
Operating income
$24.15M
+722.8% vs. a year earlier
Free cash flow
$82.18M
+34.0% vs. a year earlier
EPS, diluted
$0.53
+103.8% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $1.21B
- P/E ratio
- 51.9
- Price to sales
- 0.79
- Price to book
- 2.94
- Dividend yield
- –
- Free cash flow yield
- 6.82%
Fundamentals
- Revenue
- $1.52B
- EPS, diluted
- $0.53
- Free cash flow
- $82.18M
- Book value per share
- $9.35
- Diluted shares
- 44M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$1.52B+11.8% YoY
Gross profit
$251.70M+20.9% YoY
Operating income
$24.15M+722.8% YoY
Net income
–
EPS, diluted
$0.53+103.8% YoY
Free cash flow
$82.18M+34.0% YoY
Reported periodTrailing twelve months